{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:01:47Z","timestamp":1793289707662,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M750544"],"award-info":[{"award-number":["2024M750544"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2025D010"],"award-info":[{"award-number":["2025D010"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["BX20240089"],"award-info":[{"award-number":["BX20240089"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403703"],"award-info":[{"award-number":["82403703"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473390"],"award-info":[{"award-number":["82473390"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172739"],"award-info":[{"award-number":["82172739"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["24YF2705300"],"award-info":[{"award-number":["24YF2705300"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC3405903"],"award-info":[{"award-number":["2024YFC3405903"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jhep.2025.09.018","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:06:46Z","timestamp":1758978406000},"page":"599-617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["PARG inhibition halts cholangiocarcinoma progression via the Hippo pathway and enhances response to chemotherapy and immunotherapy"],"prefix":"10.1016","volume":"84","author":[{"given":"Mincheng","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5130-1506","authenticated-orcid":false,"given":"Peiyi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3908-6177","authenticated-orcid":false,"given":"Qiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangfu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanyuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0573-4877","authenticated-orcid":false,"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghai","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2025.09.018_bib1","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S2468-1253(24)00095-5","article-title":"Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study","volume":"9","author":"Oh","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.09.018_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bcp.2019.06.004","article-title":"Targeting poly(ADP-ribose) glycohydrolase to draw apoptosis codes in cancer","volume":"167","author":"Tanuma","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jhep.2025.09.018_bib3","article-title":"Poly(ADP-ribosyl)ating enzymes coordinate changes in the expression of metabolic genes with developmental progression","volume":"13","author":"Bordet","year":"2023","journal-title":"Scientific Rep"},{"key":"10.1016\/j.jhep.2025.09.018_bib4","article-title":"Poly(ADP-ribosyl)ating enzymes cooperate to coordinate development","volume":"12","author":"Bordet","year":"2022","journal-title":"Scientific Rep"},{"key":"10.1016\/j.jhep.2025.09.018_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25116189","article-title":"PARG protein regulation roles in Drosophila longevity control","volume":"25","author":"Bordet","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2025.09.018_bib6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1101\/gad.334516.119","article-title":"PARP and PARG inhibitors in cancer treatment","volume":"34","author":"Slade","year":"2020","journal-title":"Genes Dev"},{"key":"10.1016\/j.jhep.2025.09.018_bib7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41575-021-00571-w","article-title":"Hippo signalling in the liver: role in development, regeneration and disease","volume":"19","author":"Russell","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.09.018_bib8","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/hep.27687","article-title":"IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism","volume":"61","author":"Yamada","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.09.018_bib9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13046-022-02394-2","article-title":"The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease","volume":"41","author":"Cigliano","year":"2022","journal-title":"J Exp Clin Cancer Res\u202f: CR"},{"key":"10.1016\/j.jhep.2025.09.018_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00535-019-01563-z","article-title":"YAP and the Hippo pathway in cholangiocarcinoma","volume":"54","author":"Sugihara","year":"2019","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.09.018_bib11","doi-asserted-by":"crossref","first-page":"17206","DOI":"10.18632\/oncotarget.4043","article-title":"YAP is a critical oncogene in human cholangiocarcinoma","volume":"6","author":"Pei","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jhep.2025.09.018_bib12","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jcb.26246","article-title":"Platelet-derived growth factor regulates YAP transcriptional activity via Src family kinase dependent tyrosine phosphorylation","volume":"119","author":"Smoot","year":"2018","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jhep.2025.09.018_bib13","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1158\/1541-7786.MCR-18-0158","article-title":"YAP tyrosine phosphorylation and nuclear localization in cholangiocarcinoma cells are regulated by LCK and independent of LATS activity","volume":"16","author":"Sugihara","year":"2018","journal-title":"Mol Cancer Res\u202f: MCR"},{"key":"10.1016\/j.jhep.2025.09.018_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2022.01.026","article-title":"PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy","volume":"77","author":"Yu","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.09.018_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav4340","article-title":"Targeting dePARylation selectively suppresses DNA repair-defective and PARP inhibitor-resistant malignancies","volume":"5","author":"Chen","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.jhep.2025.09.018_bib16","doi-asserted-by":"crossref","first-page":"38738","DOI":"10.1074\/jbc.M605959200","article-title":"The ubiquitin ligase itch is auto-ubiquitylated in vivo and in vitro but is protected from degradation by interacting with the deubiquitylating enzyme FAM\/USP9X","volume":"281","author":"Mouchantaf","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2025.09.018_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1101\/gad.182618.111","article-title":"Recognition of the iso-ADP-ribose moiety in poly(ADP-ribose) by WWE domains suggests a general mechanism for poly(ADP-ribosyl)ation-dependent ubiquitination","volume":"26","author":"Wang","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.jhep.2025.09.018_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109031","article-title":"Integrative modeling and analysis of signaling crosstalk reveal molecular switches coordinating Yes-associated protein transcriptional activities","volume":"27","author":"Ghomlaghi","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.jhep.2025.09.018_bib19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.09.018_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13020318","article-title":"The Hippo signaling pathway in drug resistance in cancer","volume":"13","author":"Zeng","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jhep.2025.09.018_bib21","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jhep.2024.02.008","article-title":"Syngeneic murine models with distinct immune microenvironments represent subsets of human intrahepatic cholangiocarcinoma","volume":"80","author":"Tomlinson","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.09.018_bib22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jhep.2025.09.018_bib23","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1158\/0008-5472.CAN-12-2130","article-title":"Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma","volume":"73","author":"Mertens","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2025.09.018_bib24","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1158\/0008-5472.CAN-22-1427","article-title":"Lipid-associated macrophages are induced by cancer-associated fibroblasts and mediate immune suppression in breast cancer","volume":"82","author":"Timperi","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2025.09.018_bib25","series-title":"Proceedings of the national academy of sciences of the United States of America","first-page":"4870","article-title":"Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability [corrected]","volume":"vol 108","author":"Ho","year":"2011"},{"key":"10.1016\/j.jhep.2025.09.018_bib26","article-title":"DUB3 deubiquitylating enzymes regulate Hippo pathway activity by regulating the stability of ITCH, LATS and AMOT proteins","volume":"12","author":"Nguyen","year":"2017","journal-title":"PloS one"},{"key":"10.1016\/j.jhep.2025.09.018_bib27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/ncb2756","article-title":"Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts","volume":"15","author":"Calvo","year":"2013","journal-title":"Nat cell Biol"},{"key":"10.1016\/j.jhep.2025.09.018_bib28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2025.09.018_bib29","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.molcel.2004.07.021","article-title":"Itch E3 ligase-mediated regulation of TGF-beta signaling by modulating smad2 phosphorylation","volume":"15","author":"Bai","year":"2004","journal-title":"Mol Cel"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825025000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825025000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:58:54Z","timestamp":1777528734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827825025000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0168827825025000"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2025.09.018","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PARG inhibition halts cholangiocarcinoma progression via the Hippo pathway and enhances response to chemotherapy and immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2025.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}